140 related articles for article (PubMed ID: 37815579)
21. Intensity-modulated radiation therapy in the salvage of locally recurrent nasopharyngeal carcinoma.
Qiu S; Lin S; Tham IW; Pan J; Lu J; Lu JJ
Int J Radiat Oncol Biol Phys; 2012 Jun; 83(2):676-83. PubMed ID: 22024207
[TBL] [Abstract][Full Text] [Related]
22. Risk of temporal lobe necrosis between proton beam and volumetric modulated arc therapies in patients with different head and neck cancers.
Liu CH; Lin CY; Huang BS; Wei YC; Chang TY; Yeh CH; Sung PS; Jiang JL; Lin LY; Chang JT; Fan KH
Radiat Oncol; 2023 Sep; 18(1):155. PubMed ID: 37735389
[TBL] [Abstract][Full Text] [Related]
23. [Expression of pepsin in nasopharyngeal carcinoma and its correlation with quality of life after radiotherapy].
Zhang T; Yu GD; Jin FW; Zhou J; Tang ZP; Xian ZM; Wu Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2022 Jun; 57(6):699-705. PubMed ID: 35725312
[No Abstract] [Full Text] [Related]
24. A qualitative exploration of the fear of recurrence among Taiwanese breast cancer survivors.
Lai WS; Shu BC; Hou WL
Eur J Cancer Care (Engl); 2019 Sep; 28(5):e13113. PubMed ID: 31180170
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of phosphorylated Raf kinase inhibitory protein at serine 153 and its predictive effect on the clinical response to radiotherapy in nasopharyngeal carcinoma.
Li S; Liu T; Mo W; Hou Q; Zhou Y; Liu M; He Z; Liu Z; Chen Q; Wang H; Guo X; Xia W; Zeng M; Zhao H
Radiat Oncol; 2016 Sep; 11(1):121. PubMed ID: 27647315
[TBL] [Abstract][Full Text] [Related]
26. Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.
Jiang C; Gao H; Zhang L; Li H; Zhang T; Ma J; Liu B
BMC Cancer; 2020 Jul; 20(1):667. PubMed ID: 32680466
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for recurrent pneumonia in post-irradiated patients with nasopharyngeal carcinoma.
Wang JJ; Jiang RS; Yen TT; Liang KL
J Chin Med Assoc; 2017 Sep; 80(9):558-562. PubMed ID: 28487142
[TBL] [Abstract][Full Text] [Related]
28. Does depression decrease the moderating effect of self-efficacy in the relationship between illness perception and fear of progression in breast cancer?
Shim EJ; Lee JW; Min YH
Psychooncology; 2018 Feb; 27(2):539-547. PubMed ID: 28816370
[TBL] [Abstract][Full Text] [Related]
29. Fear of disease progression and relevant correlates in acute leukemia patients prior to allogeneic hematopoietic stem cell transplantation.
Thiele S; Goebel S; Kröger N; Pedersen A
Psychooncology; 2020 Aug; 29(8):1248-1254. PubMed ID: 32323380
[TBL] [Abstract][Full Text] [Related]
30. The Lived Experience of Inpatients With Acute Recurrent Pancreatitis: A Qualitative Research Study From West China.
Liu J; Zhang B
Gastroenterol Nurs; 2020; 43(3):249-257. PubMed ID: 32487957
[TBL] [Abstract][Full Text] [Related]
31. Fear of progression among postoperative patients with newly diagnosed lung cancer: a cross-sectional survey in China.
Chen R; Yang H; Zhang H; Chen J; Liu S; Wei L
BMC Psychol; 2023 May; 11(1):168. PubMed ID: 37217966
[TBL] [Abstract][Full Text] [Related]
32. Forty-six cases of nasopharyngeal carcinoma treated with 50 Gy radiotherapy plus hematoporphyrin derivative: 20 years of follow-up and outcomes from the Sun Yat-sen University Cancer Center.
Xu BQ; Tu ZW; Tao YL; Liu ZG; Li XH; Yi W; Jiang CB; Xia YF
Chin J Cancer; 2016 Apr; 35():37. PubMed ID: 27056488
[TBL] [Abstract][Full Text] [Related]
33. Clinical Analysis of Recurrence Patterns in Patients With Nasopharyngeal Carcinoma Treated With Intensity-Modulated Radiotherapy.
Wang L; Guo Y; Xu J; Chen Z; Jiang X; Zhang L; Huang S; He X; Zhang Y
Ann Otol Rhinol Laryngol; 2017 Dec; 126(12):789-797. PubMed ID: 29025277
[TBL] [Abstract][Full Text] [Related]
34. Nasopharyngeal carcinoma: Experience and treatment outcome with radical conformal radiotherapy from a tertiary care center in India.
Kunheri B; Agarwal G; Sunil PS; Nair AR; Pushpaja KU
Indian J Cancer; 2017; 54(3):502-507. PubMed ID: 29798947
[TBL] [Abstract][Full Text] [Related]
35. Experiences of older people following an acute exacerbation of chronic obstructive pulmonary disease: A phenomenological study.
Rosa F; Bagnasco A; Ghirotto L; Rocco G; Catania G; Aleo G; Zanini M; Dasso N; Hayter M; Sasso L
J Clin Nurs; 2018 Mar; 27(5-6):e1110-e1119. PubMed ID: 29193381
[TBL] [Abstract][Full Text] [Related]
36. Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma.
Tao CJ; Liu X; Tang LL; Mao YP; Chen L; Li WF; Yu XL; Liu LZ; Zhang R; Lin AH; Ma J; Sun Y
Chin J Cancer; 2013 Oct; 32(10):525-32. PubMed ID: 24016394
[TBL] [Abstract][Full Text] [Related]
37. Self-efficacy and fear of cancer progression during the year following diagnosis of breast cancer.
Melchior H; Büscher C; Thorenz A; Grochocka A; Koch U; Watzke B
Psychooncology; 2013 Jan; 22(1):39-45. PubMed ID: 21898655
[TBL] [Abstract][Full Text] [Related]
38. Radiation-induced abnormal cortical thickness in patients with nasopharyngeal carcinoma after radiotherapy.
Lin J; Lv X; Niu M; Liu L; Chen J; Xie F; Zhong M; Qiu S; Li L; Huang R
Neuroimage Clin; 2017; 14():610-621. PubMed ID: 28348952
[TBL] [Abstract][Full Text] [Related]
39. Correlation between the expression of miR150 and FOXO4 and the local recurrence and metastasis of nasopharyngeal carcinoma after intensive radiotherapy.
Liu B; Tan Z; Jiang Y; Chen Y; Chen Y; Ling K
J BUON; 2018; 23(6):1671-1678. PubMed ID: 30610793
[TBL] [Abstract][Full Text] [Related]
40. Clinical features and survival outcomes between ascending and descending types of nasopharyngeal carcinoma in the intensity-modulated radiotherapy era: A big-data intelligence platform-based analysis.
Yao JJ; Qi ZY; Liu ZG; Jiang GM; Xu XW; Chen SY; Zhu FT; Zhang WJ; Lawrence WR; Ma J; Zhou GQ; Sun Y
Radiother Oncol; 2019 Aug; 137():137-144. PubMed ID: 31102988
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
